Skip to Content

Division of Internal Medicine

Our mission is to provide a broad spectrum of research-driven internal medicine care for patients with cancer, including aspects of prevention, treatment and survivorship. Our vision is to continually expand our lead as a research-driven internal medicine division in a comprehensive cancer care center.

The Division of Internal Medicine comprises eight departments:

In addition to providing clinical excellence in their division practices, faculty members have developed broad-based research programs in their respective subspecialty areas.

The Life After Cancer Care Program Thanks to new, improved therapies, an increasing number of people are surviving cancer and enjoying a full life after treatment. However, we know that staying healthy can be a challenge for cancer survivors because intensive treatments create unique and long-lasting health needs. The division is committed to addressing these issues to make life after cancer as healthy and productive as possible through our Life After Cancer Care medical program. The Life After Cancer Care program provides comprehensive assessment of cancer and cancer treatment-related medical needs of cancer survivors, and recommendations for further evaluation and long-term follow-up.

Last updated September 10, 2009 (MN)

Grand Rounds and Conferences

Management of Hepatocellular Carcinoma: Efficacy and Effectiveness
October 2, 8-9 a.m.
Pickens Academic Tower
Floor 3, Rooms 3-6

Patient Decision Support Technologies in Cancer Screening and Treatment
October 9, 8-9 a.m.
Pickens Academic Tower
Floor 3, Rooms 3-6

Preoperative Evaluation of Patients Undergoing Lung Resection
October 16, 8-9 a.m.
Pickens Academic Tower
Floor 3, Rooms 3-6

Overview of Influenza: Pandemic vs. Seasonal
October 23, 8-9 a.m.
Pickens Academic Tower
Floor 3, Rooms 3-6

Opiates and Gonadal Function
October 30, 8-9 a.m.
Pickens Academic Tower
Floor 3, Rooms 3-6

Past Events

Mechanisms of Symptoms of Multiple Myeloma and Its Therapy (requires Adobe Flash Player)
Charles Cleeland, Ph.D., Bharat Aggarwal, Ph.D., Patrick Dougherty, Ph.D., Loretta Williams, Ph.D., James Reuben, Ph.D., and Xin Shelley Wang, Ph.D.
August 7, 2009


© 2009 The University of Texas M. D. Anderson Cancer Center